All manuscripts submitted to FER should abide by research and publication ethics policies of Instruction for Authors. For issues not addressed here, the guidelines of the Committee on Publication Ethics (COPE; http://publicationethics.org/resources/guidelines) should be followed. Papers should be contributed to FER along with a letter verifying that the authors have not committed plagiarism (including self-plagiarism), or duplicate publication, and have not manipulated or used fraudulent data (refer to the template of Author's confirmation regarding research ethics in the Brief Instructions for Manuscript Submission on the website). The journal uses 'CrossCheck' to check for plagiarism in submitted manuscripts.

Manuscripts submitted to FER should not have been published in any other domestic or international academic journal or non-academic publication, and should not be simultaneously submitted to another journal for consideration. If it is found that a manuscript has been submitted simultaneously to FER and another journal or that duplicate publication has occurred, the author(s) will be notified and sanctions will be imposed.

The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors' interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to pharmaceutical companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated. Any such potential conflicts of interest should be stated on the manuscript title page.

• 1) Each author must be a person who can take substantial contributions and responsibilities for the paper, and perform all of the four roles as follows. If any of these roles is lacking, the individual is considered a contributor.
  • (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;
  • (2) Drafting the work or revising it critically for important intellectual content;
  • (3) Final approval of the version to be published; AND
  • (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
• 2) Anyone who has simply assisted with acquiring funding for the work, has provided a general supervision to the researcher(s), or has carried out a simple data collection should not be listed as an author, but can instead be thanked in the Acknowledgments section.

Information on the identities of individuals (names, photos, etc.) who have participated in research should not be published in any form. Whenever any personally identifiable information has been collected, informed consent must have been provided voluntarily by the research participants. It must be stated in the manuscript that informed consent has been provided for relevant research methods.
The Korean Home Economics Association holds the copyright of all manuscripts published in FER. Written